SIGN UP
LOG IN
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga·05/27/2025 14:04:13
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Ascendiant Capital raised Pro-Dex, Inc. (NASDAQ:PDEX) price target from $54 to $56. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Pro-Dex shares closed at $46.24 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. slashed the price target for Unity Biotechnology, Inc. (NASDAQ:UBX) from $4 to $2. HC Wainwright & Co. analyst Matthew Caufield downgraded the stock from Buy to Neutral. Unity Biotechnology shares closed at $0.7790 on Friday. See how other analysts view this stock.
- JMP Securities cut Churchill Downs Incorporated (NASDAQ:CHDN) price target from $144 to $138. JMP Securities analyst Jordan Bender maintained a Market Outperform rating. Churchill Downs shares closed at $93.24 on Friday. See how other analysts view this stock.
- JMP Securities increased the price target for DBV Technologies S.A. (NASDAQ:DBVT) from $15 to $21. JMP Securities analyst Jonathan Wolleben maintained a Market Outperform rating. DBV Technologies shares closed at $8.41 on Friday. See how other analysts view this stock.
- Telsey Advisory Group increased the price target for Dollar General Corporation (NYSE:DG) from $85 to $100. Telsey Advisory Group analyst Joseph Feldman maintained a Market Perform rating. Dollar General shares closed at $101.39 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. cut Prothena Corporation plc (NASDAQ:PRTA) price target from $30 to $14. HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating. Prothena shares settled at $6.58 on Friday. See how other analysts view this stock.
- Telsey Advisory Group increased Dollar Tree, Inc. (NASDAQ:DLTR) price target from $82 to $95. Telsey Advisory Group analyst Joseph Feldman maintained a Market Perform rating. Dollar Tree shares closed at $88.17 on Friday. See how other analysts view this stock.
- Guggenheim cut Target Corporation (NYSE:TGT) price target from $155 to $115. Guggenheim analyst Robert Drbul maintained a Buy rating. Target shares closed at $94.29 on Friday. See how other analysts view this stock.
- Chardan Capital cut the price target for Prothena Corporation plc (NASDAQ:PRTA) from $40 to $18. Chardan Capital analyst Rudy Li maintained a Buy rating. Prothena shares settled at $6.58 on Friday. See how other analysts view this stock.
- Wells Fargo raised PTC Therapeutics, Inc. (NASDAQ:PTCT) price target from $68 to $74. Wells Fargo analyst Tiago Fauth maintained an Overweight rating. PTC Therapeutics shares closed at $45.93 on Friday. See how other analysts view this stock.
Considering buying PTCT stock? Here’s what analysts think:
Photo via Shutterstock
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.